While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

The biggest payoff may soon move beyond chipmakers

Willis Towers Watson's organic growth, specialty insurance expansion, AI-driven efficiencies and strong cash flow support earnings, while competition and softer rates remain risks.

Insurance brokerages are benefiting from rising demand, M&A and digitization, with Willis Towers Watson, Aon, Gallagher and Brown & Brown in focus.

Brown & Brown's strong acquisition-led growth, rising commissions and fees, and cash generation support earnings, while debt and expenses weigh on margins.

Zacks Insurance Brokerage players like WTW, AJG, AON and BRO are likely to benefit from increased demand for insurance products, strategic acquisitions and the adoption of technology.

Insurance brokerage firm Arthur J. Gallagher (NYSE:AJG) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 24.5% year on year to $4.00 billion. Its non-GAAP profit of $2.84 per share was 0.9% above analysts’ consensus estimates.

Arthur J. Gallagher & Co. (NYSE:AJG) reported second-quarter results marked by broad revenue growth, continued acquisition activity and margin expansion, while management maintained its full-year organic growth outlook despite moderating property insurance pricing. Chairman and CEO J. Patrick G

Arthur J. Gallagher (NYSE:AJG) announced the passing of Lead Independent Director David Johnson. The board appointed Ralph Nicoletti as the new Lead Independent Director following Johnson's death. These board leadership changes affect a key governance role and board oversight structure. Arthur J. Gallagher, trading at $249.42, is in focus for investors following this change in board leadership. The stock is up 89.0% over the past 5 years and 16.2% over the past 3 years, while the return...

Arthur J. Gallagher (AJG) reported Q2 2026 results that showed 24% year on year revenue growth, supported by organic expansion and acquisition integration, with earnings broadly aligned with market expectations and a continued focus on margin and M&A. See our latest analysis for Arthur J. Gallagher. Arthur J. Gallagher's share price has moved sharply around the latest Q2 update, with a 1 month share price return of 11.71% and a 90 day share price return of 23.23%, while the 1 year total...

Arthur J. Gallagher matches Q2 earnings estimates as strong organic growth and acquisitions offset higher expenses and lower interest income.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2%, and the actively tra

AJG delivers 24% total revenue growth in Q2 2026, marking 25 consecutive quarters of double-digit adjusted EBITDAC growth while navigating a softening property market.

AssuredPartners integration drives 24% revenue growth with steady organic expansion.

While the top- and bottom-line numbers for Arthur J. Gallagher (AJG) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 0.00% and -1.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Insurance brokerage firm Arthur J. Gallagher (NYSE:AJG) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 24.5% year on year to $4.00 billion. Its non-GAAP profit of $2.84 per share was 0.9% above analysts’ consensus estimates.

Insurance brokerage firm Arthur J. Gallagher (NYSE:AJG) will be announcing earnings results this Thursday after market hours. Here’s what to look for.

Evaluate the expected performance of Arthur J. Gallagher (AJG) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

AJG's Q2 results are likely to benefit from brokerage strength, higher commissions and acquisition contributions despite rising expenses.

Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Investing.com -- Piper Sandler on Tuesday outlined a new investment strategy for a softening U.S. property and casualty insurance market, arguing investors should rotate within the sector rather than exit it as commercial insurance pricing weakens.

IBM downgraded, Cava upgraded: Wall Street's top analyst calls

Arthur J. Gallagher (NYSE:AJG) has acquired Med James, Inc., a Kansas based managing general agency and wholesale insurance broker. The transaction expands Gallagher's specialty insurance platform and will be integrated into its Risk Placement Services division. The deal broadens Gallagher's reach with retail agents that rely on customized and niche insurance solutions. For investors tracking Arthur J. Gallagher, this move adds detail to the story around its insurance brokerage and risk...

Arthur J. Gallagher stock has delivered a 101.5% return over the past 5 years, yet its current checks send mixed valuation signals, with an intrinsic value estimate from the Excess Returns model pointing to a discount while market multiples lean the other way. A 101.5% 5 year return sets the bar higher for new investors, as a lot of the earlier upside has already played out in the share price. Ongoing acquisitions that expand Gallagher's brokerage and specialty insurance footprint can...

Arthur J. Gallagher (AJG) has caught investor attention after a recent stretch of positive share performance, with the stock up 3.2% over the past week and 19.5% over the past month. See our latest analysis for Arthur J. Gallagher. Set against a 1 day share price return of 3.2% and a 90 day share price return of 18.8%, Arthur J. Gallagher's 1 year total shareholder return, including dividends, has fallen 16.2%. This means recent momentum contrasts with weaker longer term results. If you are...